Zhitong Finance App News, Haohai Biotechnology (06826) announced that with effect from August 21, 2026: Mr. Huang Ming, a non-executive director of the company, will no longer serve as the authorized representative of the company under section 3.05 of the Hong Kong Stock Exchange Limited securities listing rules; Ms. Tian Min, the company's executive director and joint company secretary, has been appointed as an authorized representative. The company's co-company secretary, Ms Lai Ying-tung, remains another authorized representative.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.